| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |